ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA

Clinical trials for ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA trials appear

Sign up with your email to follow new studies for ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New pill tested for Tough-to-Treat brain cancers

Disease control Recruiting now

This is the first study in people testing an experimental pill called ONC206 for adults with recurrent brain tumors that have few treatment options. The main goal is to find the highest safe dose and understand the side effects. Researchers will enroll about 102 patients to test …

Matched conditions: ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA

Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA

Get alerted when new ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA trials appear

New pill tested for Tough-to-Treat brain cancers